Elevated Eosinophil Levels Websites
CINQAIR.com – CINQAIR® (reslizumab) Injection now approved
CINQAIR® (reslizumab) Injection is now approved as an add-on treatment for adults (18 years and older) with severe asthma and elevated eosinophil levels
Not Applicable
$
8.95
